Metabolic dysfunction‐associated steatotic liver disease and cancer risk: A cohort study
All subcategories of SLD, particularly MASLD with multiple metabolic abnormalities, were associated with increased risks of multiple cancers, providing a new perspective for cancer prevention.
Authors
- Xixuan Wang
- Huijun Zhou (ORCID: https://orcid.org/0000-0001-9950-7693)
- Changyu Si
- Jicheng Gong (ORCID: https://orcid.org/0000-0002-8943-8804)
- Fangfang Song (ORCID: https://orcid.org/0000-0003-3998-8506)
- Peng Wang (ORCID: https://orcid.org/0000-0003-4666-9706)
- Peng Yu (ORCID: https://orcid.org/0009-0008-0345-5787)
- Fubin Liu (ORCID: https://orcid.org/0000-0001-9370-3861)
- Jiale Gu
- A. Qin
- Weijie Song
Institutions
- Tianjin Medical University Cancer Institute and Hospital (CN)
Publication Details
- Journal
- Diabetes Obesity and Metabolism
- Published
- 2025-01-09
- DOI
- https://doi.org/10.1111/dom.16186
- Citations
- 9
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 12.19
Funders
- National Key Research and Development Program of China